The moment a prescription is written is often treated like the finish line. In reality, it’s frequently just the beginning of a complicated process filled with obstacles that can delay, disrupt, or derail treatment, including financial hurdles, treatment complexity, fragmented support, and long-term adherence challenges.
For many patients, therapy never truly starts, while others abandon treatment weeks or months later because ongoing support systems break down.
While affordability has long been a primary focus throughout the healthcare industry, other factors that contribute to medication success and improved patient outcomes have often received less attention.
From administrative delays and fragmented care coordination to limited ongoing support, patients face a series of hurdles beyond affordability that can prevent them from starting therapy or remaining on it long enough to achieve the intended outcome.
The ripple effects are substantial, contributing to poorer patient outcomes, rising healthcare costs, avoidable hospitalizations, and a significant economic burden nationwide.
To address these challenges, TailorMed has built a network designed to connect the fragmented pieces of the medication journey. By bringing together providers, pharmacies, life sciences companies, and patient support programs, the company works to identify barriers earlier and deliver the right resources at the right time, helping more patients access treatment, start therapy sooner, and remain on it longer.
“Affordability is a huge problem and remains at the heart of what we do,” said Srulik Dvorsky, co-founder and CEO of TailorMed, in a company announcement. “But for patients, it’s rarely the only challenge.”
That insight is driving TailorMed’s next phase of growth.
TailorMed built its reputation by helping patients overcome affordability barriers and access life-changing therapies. Now, the company is broadening that mission. Building on its market-leading affordability platform, TailorMed is expanding its focus to address access, support, and adherence challenges across the medication journey.
This move marks the next chapter in TailorMed’s evolution, building on its leadership in affordability while expanding its focus to the broader challenges that impact medication success.
Connecting Fragmented Systems
TailorMed’s scale has grown significantly in recent years.
Since 2020, TailorMed says it has secured $7.4 billion in financial assistance for patients.
TailorMed’s expansion reflects the reality that affordability is only one piece of the medication journey. Patients often face additional barriers after a prescription is written, underscoring the need for better coordination, support, and engagement.
Healthcare systems are increasingly struggling with operational fragmentation. Patients move between providers, pharmacies, payers, manufacturers, and support programs that often operate independently of one another. That fragmentation creates delays, administrative burden, and treatment abandonment that ultimately impact both patient outcomes and healthcare economics.
TailorMed is working to bridge those gaps through a more unified platform model and coordinated approach to medication support.
To support that effort, TailorMed recently expanded its platform with solutions designed to address different points along the medication journey. Together, these solutions are intended to create a coordinated infrastructure to improve access and affordability while supporting long-term adherence.
Strain Across Healthcare Stakeholders
The timing of TailorMed’s expansion reflects larger pressures building across healthcare.
As specialty drugs, oncology therapies, and cell and gene treatments continue to grow in both complexity and cost, healthcare organizations are under increasing pressure to improve medication initiation and adherence rates while simultaneously reducing administrative burden.
Hospitals and health systems are also facing tighter margins, staffing shortages, and growing operational strain tied to reimbursement and care coordination.
In that environment, technology platforms that can reduce friction across the medication journey are becoming strategically important.
Helping patients access financial assistance remains important. An equally important challenge is ensuring patients can navigate delays, fragmented care coordination, support gaps, and other obstacles that often stand between a prescription and successful treatment.
That’s a significantly bigger ambition than traditional affordability tools alone.
And it reflects a broader trend unfolding across digital health, where the next generation of healthcare infrastructure companies are competing not just on features, but on network scale, interoperability, and embedded workflow integration.
A Connected Network
One of the key differentiators behind TailorMed is the scale and connectivity of its growing network.
The company says its network now includes more than 5,000 hospitals and clinics, 3,100 pharmacies, and over 100 pharmaceutical program partnerships. Collectively, the platform reaches more than 75 million patients nationwide and supports approximately 335 million prescriptions annually.
“The power of the TailorMed network lies in the diversity of its participants and the magnitude of its reach,” Dvorsky said.
That type of connected infrastructure strategy has become increasingly important across healthcare technology, particularly as organizations seek ways to share data, streamline workflows, and coordinate patient support more effectively without introducing additional operational complexity.
In many ways, TailorMed’s evolution mirrors a broader shift happening throughout healthcare innovation, which is the movement away from isolated tools and toward connected operational ecosystems designed to improve outcomes at scale.
The prescription may still mark the beginning of treatment. But increasingly, success depends on helping patients navigate everything that comes after, from access and support to long-term adherence, a challenge TailorMed is working to address.
